Region of factor IXa protease domain that interacts with factor vIIIa: Analysis of select hemophilia B mutants

Thrombosis and Haemostasis

Volumn 82, Issue 2, 1999, Pages 218-225

  Bajaj, S Paul ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8A; BLOOD CLOTTING FACTOR 9A; PROTEINASE;

AMINO ACID SEQUENCE; BLOOD CLOTTING; CONFERENCE PAPER; CRYSTAL STRUCTURE; GENE SEQUENCE; GENETIC ORGANIZATION; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HUMAN; MOLECULAR MODEL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; X CHROMOSOME;

EID: 0032746250     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615836     Document Type: Conference Paper

References (53)

1. Pavlovsky A. Contribution of pathogenesis to hemophilia. Blood. 1947;2:185-191.
2. Biggs R, Douglas AS, Macfarlane RG, Dacie JV, Pitney WR, Merskey C, O'Brien JR. Christmas disease, a condition previously mistaken for hemophilia. Br Med J. 1952;2:1378-1387.
3. Davie EW, Fujikawa K, Kiesiel W. The coagulation cascade. Initiation, maintenance and regulation. Biochemistry. 1991;30:10363-10370.
4. Anson DS, Choo KH, Rees DJG, Giannelli, F, Gould K, Huddleston JA, Brownlee GG. The gene structure of human antihemophilic factor IX. EMBO J. 1984;3:1053-1060.
5. Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry. 1985;24:3736-3750.
6. Kurachi K, Kurachi S. Regulatory mechanism of the factor IX gene. Thromb Haemost. 1995;73:333-339.
7. 2-Gle) O-glycosidically linked to a serine residue in the first epidermal growth factor-like domain of human factors VII and IX and protein Z and bovine protein Z. J Biol Chem. 1989;264:20320-20325.
8. Nishimura H, Takao T, Hase S, Shimonishi Y, Iwanaga S. Human factor IX has a tetrasaccharide O-glycosidically linked to serine 61 through the fucose residue. J Biol Chem. 1992;267:17520-17525.
9. Harris RJ, van Halbeek H, Glushka J, Basa LJ, Ling VT, Smith KJ, Spellman MW. Identification and structural analysis of the tetrasaccharide NeuAc alpha (266) Gal beta (164) GlcNAc beta (163) Fuc alpha 160-linked to serine 61 of human factor IX. Biochemistry. 1993;32:6539-6547.
10. Agarwala KL, Kawabata S, Takao T, Murata H, Shimonishi Y, Nishimura H, Iwanaga S. Activation peptide of human factor IX has oligosaccharides O-glycosidically linked to threonine residues at 159 and 169. Biochemistry. 1994;33:5167-5171.
11. DiScipio RG, Kurachi K, Davie EW. Activation of human factor IX (Christmas factor). J Clin Invest. 1978;61:1528-1538.
12. Østerud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA. 1977;74:5260-5264.
13. Bajaj SP, Rapaport SI, Russell WA. Redetermination of the rate limiting step in the activation of factor IX by factor Xla and by factor Vlla/tissue factor. Biochemistry. 1983;22:4047-4053.
14. Lawson JH, Mann KG. Cooperative activation of human factor IX by the human extrinsic pathway of blood coagulation. J Biol Chem. 1991;266:11317-11327.
15. Brandstetter H, Bauer M, Huber R, Lollar P, Bode W. X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B. Proc Natl Acad Sci USA. 1995;92:9796-9800.
16. Banner DW, D'Arcy A, Chene C, Winkler FK, Guha A, Konigsberg WH, Nemerson Y, Kirchhofer D. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature. 1996;380:41-46.
17. Sabharwal AK, Padmanabhan K, Tulinsky A, Mathur A, Gorka J, Bajaj SP. Interaction of calcium with native and decarboxylated human factor X. J Biol Chem. 1997;272:22037-22045.
18. 2+ with human factor IX. Arch Biochem Biophys. 1981;208:576-585.
19. 2+-binding to human factor IX. J Biol Chem. 1982;257:4127-4132.
20. Freedman SJ, Furie BC, Furie B, Baleja JD. Structure of the calcium ion-bound gamma-carboxyglutamic acid-rich domain of factor IX. Biochemistry. 1995;34:12126-12137.
21. 2+-binding epidermal growth factor-like domain; its role in protein-protein interactions. Cell. 1995;82:131-141.
22. 2+-binding site in the protease domain. Proc Natl Acad Sci USA. 1992;89:152-156.
23. Bajaj SP, Birktoft JJ. Human factor IX and factor IXa. Methods Enzymol. 1993;222:96-128.
24. Freedman SJ, Blostein MD, Baleja JD, Jacobs M, Furie BC, Furie B. Identification of the phospholipid binding site in the vitamin K-dependent blood coagulation protein factor IX. J Biol Chem. 1996;271:16227-16236.
25. Ahmad SS, Wong MY, Rawala R, Jameson BA, Walsh PN. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex. Biochemistry. 1998;37:1671-1679.
26. Zhong D, Smith KJ, Birktoft JJ, Bajaj SP. First epidermal growth factor-like domain of human blood coagulation factor IX is required for its activation by factor VIIa/tissue factor but not by factor XIa. Proc Natl Acad Sci USA. 1994;91:3574-3578.
27. 2+-binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding. J Biol Chem. 1996;271:25332-25337.
28. Ahmed SS, Rawala R, Cheung WF, Stafford DW, Walsh PN. The role of the second growth-factor domain of human factor IXa in binding to platelets and in factor X activation. Biochem J. 1995;310:427-431.
29. Bajaj SP, Rapaport SI, Maki SL. A monoclonal antibody to factor IX that inhibits the factor VIII potentiation of factor X activation. J Biol Chem. 1985;260:11574-11580.
30. Astermark J, Hogg PJ, Stenflo J. The gamma-carboxyglutamic acid and epidermal growth factor-like modules of factor IXaβ. Effects on the serine protease module and factor X activation. J Biol Chem. 1994;269:3682-3689.
31. O'Brien LM, Medved LV, Fay PJ. Localization of factor IXa and factor VIIIa interactive sites. J Biol Chem. 1995;270:27087-27092.
32. Frazier D, Smith KJ, Cheung W-F, Ware J, Lin S-W, Thompson AR, Reisner H, Bajaj SP, Stafford DW. Mapping of monoclonal antibodies to human factor IX. Blood. 1989;74:971-977.
33. Ludwig M, Sabharwal AK, Brackmann HH, Olek K, Smith KJ, Birktoft JJ, Bajaj SP. Hemophilia B caused by five different nondeletion mutations in the protease domain of factor IX. Blood. 1992;79:1225-1232.
34. Hamaguchi N, Bajaj SP, Smith KJ, Stafford DW. The role of amino-terminal residues of the heavy chain of factor IXa in the binding of its cofactor, factor VIIIa. Blood. 1994;84:1837-1842.
35. 2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X. J Biol Chem. 1997;272:23418-23426.
36. Giannelli F, Green PM, Sommer SS, Poon MC, Ludwig M, Schwaab R, Reitsma PH, Goossens M, Yoshioka A, Brownlee GG. Haemophilia B (sixth edition): a database of point mutations and short additions and deletions. Nucleic Acids Res. 1996;24:103-118.
37. Mathur A, Smith KJ, Bajaj SP. Importance of helix-162 (chymotrypsin numbering) of factor IXa in its interaction with factor VIIIa. Protein Sci. 1998;7(Suppl 1):135.
38. Mathur A, Zhong D, Smith KJ, Bajaj SP. Protease and EGF1 domains of factor IXa play distinct roles in binding to factor VIIIa. Blood. 1998;92(Suppl 1):352a.
39. Mathur A, Bajaj SP. Protease and EGF1 domains of factor IXa play distinct roles in binding to factor VIIIa: Importance of helix-330 (helix-162 in chymotrypsin) of protease domain of factor IXa in its interaction with factor VIIIa. J Biol Chem. 1999;274:18477-18486.
40. Chang J, Jin J, Lollar P, Bode W, Brandstetter H, Hamaguchi N, Straight DL, Stafford DW. Changing residue 338 in human factor IX from arginine to alanine causes an increase in catalytic activity. J Biol Chem. 1998;273:12089-12094.
41. Rees DJ, Jones IM, Handford PA, Walter SJ, Esnouf MP, Smith KJ, Brownlee GG. The role of beta-hydroxyaspartate and adjacent carboxylate residues in the first EGF domain of human factor IX. EMBO J. 1988;7:2053-2061.
42. Hughes PE, Morgan G, Rooney EK, Brownlee GG, Handford P. Tyrosine 69 of the first epidermal growth factor-like domain of human factor IX is essential for clotting activity. J Biol Chem. 1993;268:17727-17733.
43. Chang JL, Jin JP, Straight DL, Stafford DW. Residues 330-338 in catalytic domain of factor IX represent an interactive site for both factor VIIIa and factor X. Blood. 1998;92(Suppl 1):184a.
44. Mather T, Oganessyan V, Hof P, Huber R, Foundling S, Esmon C, Bode W. The 2.8 Å crystal structure of Gla-domainless activated protein C. EMBO J. 1996;15:6822-6831.
45. Jones TA, Zou JY, Cowan SW, Kjeldgaard M. Improved methods for the building of protein models in electron density maps and the location of errors in these models. Acta Crystallogr 1991;A47:110-119.
46. Lin S-W, Smith KJ, Welsch D, Stafford DW. Expression and characterization of human factor IX and factor IX-factor X chimeras in mouse C127 cells. J Biol Chem. 1990;265:144-150.
47. Chang JY, Monroe DM, Stafford DW, Brinkhous KM, Roberts HR. Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B. J Clin Invest. 1997;100:886-892.
48. McCord DM, Monroe DM, Smith KJ, Roberts HR. Characterization of the functional defect in factor IX Alabama. J Biol Chem. 1990;265:10250-10254.
49. 55 by Ala in the first epidermal growth factor-like domain. Blood. 1990;76:1530-1537.
50. Christophe OD, Lenting PJ, Kolkman JA, Brownlee GG, Mertens K. Blood coagulation factor IX residues Glu78 and Arg94 provide a link between both epidermal growth factor-like domains that is crucial in the interaction with factor VIII light chain. J Biol Chem. 1998;237:222-227.
51. Larson PJ, Stanfield-Oakley SA, VanDusen WJ, Kasper CK, Smith KJ, Monroe DM, High KA. Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa is required for its binding to cofactor VIIIa. J Biol Chem. 1996;271:3869-3876.
52. Fay PJ, Koshibu K. The A2 subunit of factor VIIIa modulates the active site of factor IXa. J Biol Chem. 1998;273:19049-19054.
53. Bajaj SP, Miletich JP. Unpublished data.